BSE 765.85 NSE 766.10
BSE 765.85 NSE 766.10

Mr. Mark D. McDade

Independent Director

Mr. McDade has had a biopharmaceutical career spanning more than 37 years, where he has held a progression of COO and CEO roles in complex businesses. He was most recently a lead executive at UCB Pharma, where he was exceptionally well-regarded and credited with providing steady and resilient leadership during a time of significant transformation. Mr. McDade has a breadth of experience with small and large molecule products in a wide range of therapeutic areas, and has a strong track record of developing, launching, scaling, and managing commercial products. He is the Co-Founder and Partner at Qiming Venture Partners, USA where since 2017 he has built a strong investment team, raised three funds and from which numerous high value investments have been made in novel biotherapeutics, including cell and gene therapy, as well as digital health companies. Mr. McDade is currently on the Corporate Boards of LetsGetChecked, Inc., Ireland, Talaris Therapeutics, Inc., USA, Soda Health, USA, as well as the board chair of Icosavax, Inc., USA.

Education
  • Bachelor of Arts from Dartmouth College, Hanover
  • MBA from Harvard Business School, Boston
Age 67 years
Nationality US
Appointed January 28, 2021
Tenure 1.2 years
Committee Membership Member of the Risk Management Committee

Appointment Letter

DOWNLOAD NOW